H
Haemonetics Corporation
HAE · NYSE · Healthcare · 4.1B
Price · close
$108.80
+0.54% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
52.8×
Price / net assetsP/B
6.4×
Enterprise value / EBITDAEV/EBITDA
19.6×
Free cash flow yieldFCF yield
5.1%
Return on equityROE
12.2%
Operating margin
18.1%
Net debt / EBITDAbalance-sheet strength
3.1×
Interest coverage
8.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.